Nuvelution Pharma Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Nuvelution Pharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11010
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nuvelution Pharma Inc (Nuvelution Pharma) is a developer of late-stage clinical assets. The company offers research and development risk-sharing approach to pharmaceutical and biotechnology companies. It facilitates advancement of late-stage clinical assets where research and development budget constraints have delayed their further development. Nuvelution Pharma offers research and development, clinical trial design and execution, financing, human resources services to bring products with significant commercial potential to the market, and allows the companies to maintain commercialization rights. The company serves its clients across the US. Nuvelution Pharma is headquartered in South San Francisco, California, the US.

Nuvelution Pharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Nuvelution Pharma Raises Funds in Venture Financing 10
Partnerships 11
Nuvelution Pharma Enters into Agreement with Amgen 11
Teva Pharma and Nuvelution Pharma Enter into Agreement 12
Nuvelution Pharma Inc – Key Competitors 13
Nuvelution Pharma Inc – Key Employees 14
Nuvelution Pharma Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Oct 25, 2018: Nuvelution Pharma appoints Kirk ways, M.D., Ph.D., as Chief Medical Officer 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuvelution Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nuvelution Pharma Raises Funds in Venture Financing 10
Nuvelution Pharma Enters into Agreement with Amgen 11
Teva Pharma and Nuvelution Pharma Enter into Agreement 12
Nuvelution Pharma Inc, Key Competitors 13
Nuvelution Pharma Inc, Key Employees 14

List of Figures
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Nuvelution Pharma Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • C&D Technologies Inc:企業の戦略的SWOT分析
    C&D Technologies Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Coresa Sa:企業の戦略・SWOT・財務分析
    Coresa Sa - Strategy, SWOT and Corporate Finance Report Summary Coresa Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • HL Global Enterprises Limited:企業の戦略・SWOT・財務情報
    HL Global Enterprises Limited - Strategy, SWOT and Corporate Finance Report Summary HL Global Enterprises Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Lactalis Ingredients:企業の戦略・SWOT・財務情報
    Lactalis Ingredients - Strategy, SWOT and Corporate Finance Report Summary Lactalis Ingredients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Vestel Elektronik Sanayi Ve Ticaret AS:企業の戦略・SWOT・財務分析
    Vestel Elektronik Sanayi Ve Ticaret AS - Strategy, SWOT and Corporate Finance Report Summary Vestel Elektronik Sanayi Ve Ticaret AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Murree Brewery Co. Ltd.:企業の戦略・SWOT・財務情報
    Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Maquet Holding BV & Co KG:企業の戦略的SWOT分析
    Maquet Holding BV & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Eli Lilly and Co (LLY):企業の財務・戦略的SWOT分析
    Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • GBST Holdings Limited (GBT):企業の財務・戦略的SWOT分析
    GBST Holdings Limited (GBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • BTB Real Estate Investment Trust:企業の戦略・SWOT・財務分析
    BTB Real Estate Investment Trust - Strategy, SWOT and Corporate Finance Report Summary BTB Real Estate Investment Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Genomind Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genomind Inc (Genomind) is a personalized medicine company that provides genetic testing services. The company offers Genecept Assay, a pharmacogenetic test designed to help clinicians optimize treatment decisions for their patients with mental illness. Its test is used to guide treatment fo …
  • Central Alabama Electric Cooperative Inc:企業の戦略的SWOT分析
    Central Alabama Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Australian Securities & Investments Commission:企業の戦略的SWOT分析
    Australian Securities & Investments Commission - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Cellerant Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Cellerant Therapeutics Inc (Cellerant) develops novel immunotherapies for oncology and blood-related disorders. Its lead product, CLT-008, is a myeloid progenitor cell therapy which is in Phase 2 clinical development in patients with acute myeloid leukemia (AML). Cellerant develops various c …
  • Lee Enterprises Inc (LEE):企業の財務・戦略的SWOT分析
    Lee Enterprises Inc (LEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Unipol Gruppo Finanziario S.p.A.:戦略・SWOT・企業財務分析
    Unipol Gruppo Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Unipol Gruppo Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Cafe De Coral Holdings Limited:企業の戦略・SWOT・財務分析
    Cafe De Coral Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Cafe De Coral Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Steel Authority Of India Ltd:企業の戦略・SWOT・財務分析
    Steel Authority Of India Ltd - Strategy, SWOT and Corporate Finance Report Summary Steel Authority Of India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Aristocrat Leisure Ltd (ALL):企業の財務・戦略的SWOT分析
    Aristocrat Leisure Ltd (ALL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Mitel Networks Corporation:企業のM&A・事業提携・投資動向
    Mitel Networks Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitel Networks Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆